Geron (GERN) Interest Coverage Ratio Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 15.31%
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -76.51%
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -303.06%
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn -26.72%
8 Evaxion A 65.44 Bn 65.42 Bn - 18.06%
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 1,150.63%
10 Geron 856,799.98 856,799.98 - 101.09%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 101.09%
Dec 31, 2025 -51.98%
Sep 30, 2025 82.66%
Jun 30, 2025 93.00%
Mar 31, 2025 87.54%
Dec 31, 2024 90.15%
Sep 30, 2024 59.81%
Jun 30, 2024 19.46%
Mar 31, 2024 21.61%
Dec 31, 2023 -11.79%
Sep 30, 2023 -4.82%
Jun 30, 2023 -46.57%
Mar 31, 2023 -7.59%
Dec 31, 2022 23.35%
Sep 30, 2022 9.40%
Jun 30, 2022 50.75%
Mar 31, 2022 49.37%
Dec 31, 2021 11.54%
Sep 30, 2021 99.27%
Mar 31, 2021 90.01%
Dec 31, 2020 -101.34%
Sep 30, 2020 -610.11%
Mar 31, 2020 38.93%
Dec 31, 2019 581.45%
Sep 30, 2019 -293.48%
Jun 30, 2019 -313.43%
Mar 31, 2019 -51.96%
Dec 31, 2018 -10.84%
Sep 30, 2018 70.33%
Jun 30, 2018 63.53%
Mar 31, 2018 -15.78%
Dec 31, 2017 -8.37%
Sep 30, 2017 -117.99%
Jun 30, 2017 28.24%
Mar 31, 2017 17.44%
Dec 31, 2016 7.65%
Sep 30, 2016 -115.03%
Jun 30, 2016 -8.85%
Mar 31, 2016 -9.71%
Dec 31, 2015 -0.72%
Sep 30, 2015 372.74%
Jun 30, 2015 -14.39%
Mar 31, 2015 27.80%
Dec 31, 2014 44.48%
Sep 30, 2014 38.12%
Jun 30, 2014 41.18%
Mar 31, 2014 18.04%
Dec 31, 2013 24.73%
Sep 30, 2013 -688.39%
Jun 30, 2013 30.69%
Mar 31, 2013 19.05%
Dec 31, 2012 -99.25%
Sep 30, 2012 47.22%
Jun 30, 2012 -33.74%
Mar 31, 2012 -11.44%
Dec 31, 2011 15.27%
Sep 30, 2011 -149.96%
Jun 30, 2011 -2.34%